Top Tech Companies (28)
Technorely is a software development and IT outsourcing company with head offices in Vancouver and Washington DC. We offer solutions both for startups and established businesses. You can rely on us in: ▫️ Blockchain | Full-cycle of blockchain development at the most popular platforms - Ethereum, Stellar, Hyperledger and EOS ▫️ Support & Customization | Effective IT support, system improvement and maintenance ▫️ Web Application Development ▫️ Mobile Application Development | Mobile Apps for IOS and Android - native and cross-platform ▫️ Desktop | Apps for macOS, Windows and Linux ▫️ Quality Assurance ▫️ UX/UI | Web and Mobile Design ▫️ Business Analytics Our team includes the developers and IT experts willing to contribute their profound knowledge and expertise to your projects. Our main services are Team Extension and Dedicated Team. Our team is experienced in Fintech, Healthcare, Industrial and Blockchain areas. We can guarantee a proactive approach and high dedication to your project as well as the best possible quality of work, that is why European and American companies choose us as their reliable partners. We are the pioneers of blockchain. Our specialists are agile and goal-oriented. Whether you need an experienced team extension or an efficient team that implements your idea of any complexity, we have got you covered
Evasc is a medical device company focused on novel solutions for the endovascular repair of cerebral aneurysms, to provide a much higher standard of care and rate of successful treatment outcomes than previously possible
An Intelligent Health Imaging Platform, benefiting imaging healthcare specialists and those they serve. Patents pending
At PAI Health, our mission is to become the global health standard for physical activity by delivering personalized digital solutions to promote, inspire and instill active lifestyle habits that lead to improved health outcomes and quality of life. Our strategic alliances include corporate wellness and health platforms, insurance companies, wearable manufacturers, and other industry partners. Creative and collaborative working practices are at the core of PAI Health. We are constantly striving to be at the forefront of positive social change and have crafted an inclusive and diverse company culture, which welcomes all to come and thrive here at PAI Health. For more information about careers at PAI Health, check out www.paihealth.com/careers
Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes. Our first-in-class therapeutic is focused on improving glucagon counterregulation by inhibiting somatostatin which is dysregulated in Type 1 diabetes. Preventing hypoglycemia will dramatically change diabetes disease management, improving both patient health and quality of life.
Vesalius Cardiovascular is a Canadian medical device company founded in 2016 in Vancouver, Canada. The company specializes in designing and developing biomedical devices for the treatment of cardiovascular disease, specifically mitral valve regurgitation (MR). We are preclinical. Our devices will be introduced percutaneously (transfemoral/transseptal) to the heart, eliminating the need for open heart surgery and the related risks. The procedure can be performed by a Cardiovascular Interventionalist (Cardiologist or Cardiac Surgeon). Vesalius Cardiovascular is the result of several years of intensive private research and investigation. The inventor behind Vesalius Cardiovascular is Dr. Peter Skarsgard, a Vancouver-based Cardiac Surgeon, and Head of the Division of Cardiovascular Surgery at Vancouver General Hospital. Our Advisory Board includes some of BC’s most prominent clinicians, including: - Peter Skarsgard (MD), Cardiac Surgeon and Head of Cardiovascular Surgery at VGH - Christopher Durkin (MD), Anaesthesiologist with advanced expertise in 3D echo for intracardiac structural disease - Jacqueline Saw (MD), Interventional Cardiologist with specialized expertise in percutaneous device delivery and structural heart intervention Vesalius Cardiovascular is currently developing Calla, a biomedical device that can be introduced percutaneously (transfemoral/transseptal) to the heart, for the treatment of degenerative MR (due to mitral valve prolapse), the most common variety of MR. The principles of surgical mitral valve repair are utilized, but sternotomy, heart-lung bypass, and cardiac arrest - components of an open heart operation - are not required
Avivo, a British Columbia-based preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type. This innovative platform enables a world where a person’s blood type is no longer the first constraint when they need life-saving organ transplants or blood transfusions. Avivo’s platform will enable healthcare providers to better prioritize patients by medical urgency, spend less on management and logistics and ultimately save more lives.
Join a team connected by collaboration, support and most importantly, the goal of providing quality patient care. We value career growth with employer-supported training, encourage a culture where everyone’s voice is heard and strive to create a supportive team environment. To learn more, visit vch.ca/careers Facebook - https://www.facebook.com/VCHhealthcare/ Twitter - https://twitter.com/VCHhealthcare YouTube - https://www.youtube.com/@VCHhealthcare Instagram - https://www.instagram.com/vchhealthcare/
